| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |